Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chong-Jen Yu

Showing results (351-360 of 478) with videos related to

Pageof 48
Sort By:
Oncotarget|December 25, 2014
Afatinib induces apoptosis in NSCLC without EGFR mutation through Elk-1-mediated suppression of CIP2ATing-Ting Chao, Cheng-Yi Wang, Yen-Lin Chen, et al.
Molecular Oncology|November 5, 2020
Multi-kinase framework promotes proliferation and invasion of lung adenocarcinoma through activation of dynamin-related protein 1Kuei-Pin Chung, Yen-Lin Huang, Yi-Jung Chen, et al.
Critical Care (London, England)|April 5, 2011
Life expectancies and incidence rates of patients under prolonged mechanical ventilation: a population-based study during 1998 to 2007 in TaiwanMei-Chuan Hung, Hsin-Ming Lu, Likwang Chen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 16, 2010
Chemotherapy response in East Asian non-small cell lung cancer patients harboring wild-type or activating mutation of epidermal growth factor receptorsChia-Chi Lin, Hsin-Hsin Hsu, Chia-Tung Sun, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 22, 2013
Antimicrobial drug-resistant microbes associated with hospitalized community-acquired and healthcare-associated pneumonia: a multi-center study in TaiwanChieh-Liang Wu, Shih-Chi Ku, Kuang-Yao Yang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 17, 2014
Signal transducer and activator of transcription 3 as molecular therapy for non-small-cell lung cancerCheng-Yi Wang, Ting-Ting Chao, Wei-Tien Tai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Predictive factors of gefitinib antitumor activity in East Asian advanced non-small cell lung cancer patientsGee-Chen Chang, Chun-Ming Tsai, Kun-Chieh Chen, et al.
JAMA Oncology|January 1, 2016
First-Line Erlotinib Therapy Until and Beyond Response Evaluation Criteria in Solid Tumors Progression in Asian Patients With Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer: The ASPIRATION StudyKeunchil Park, Chong-Jen Yu, Sang-We Kim, et al.
Medicine|June 4, 2016
Risk of Tuberculosis Among Patients on Dialysis: The Predictive Value of Serial Interferon-Gamma Release AssayChin-Chung Shu, Chia-Lin Hsu, Yu-Feng Wei, et al.
BMJ Open Respiratory Research|August 2, 2023
Deep learning with test-time augmentation for radial endobronchial ultrasound image differentiation: a multicentre verification studyKai-Lun Yu, Yi-Shiuan Tseng, Han-Ching Yang, et al.
Pageof 48

Showing results (351-360 of 478) with videos related to

Sort By:
Pageof 48
Oncotarget|December 25, 2014
Afatinib induces apoptosis in NSCLC without EGFR mutation through Elk-1-mediated suppression of CIP2ATing-Ting Chao, Cheng-Yi Wang, Yen-Lin Chen, et al.
Molecular Oncology|November 5, 2020
Multi-kinase framework promotes proliferation and invasion of lung adenocarcinoma through activation of dynamin-related protein 1Kuei-Pin Chung, Yen-Lin Huang, Yi-Jung Chen, et al.
Critical Care (London, England)|April 5, 2011
Life expectancies and incidence rates of patients under prolonged mechanical ventilation: a population-based study during 1998 to 2007 in TaiwanMei-Chuan Hung, Hsin-Ming Lu, Likwang Chen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 16, 2010
Chemotherapy response in East Asian non-small cell lung cancer patients harboring wild-type or activating mutation of epidermal growth factor receptorsChia-Chi Lin, Hsin-Hsin Hsu, Chia-Tung Sun, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 22, 2013
Antimicrobial drug-resistant microbes associated with hospitalized community-acquired and healthcare-associated pneumonia: a multi-center study in TaiwanChieh-Liang Wu, Shih-Chi Ku, Kuang-Yao Yang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 17, 2014
Signal transducer and activator of transcription 3 as molecular therapy for non-small-cell lung cancerCheng-Yi Wang, Ting-Ting Chao, Wei-Tien Tai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Predictive factors of gefitinib antitumor activity in East Asian advanced non-small cell lung cancer patientsGee-Chen Chang, Chun-Ming Tsai, Kun-Chieh Chen, et al.
JAMA Oncology|January 1, 2016
First-Line Erlotinib Therapy Until and Beyond Response Evaluation Criteria in Solid Tumors Progression in Asian Patients With Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer: The ASPIRATION StudyKeunchil Park, Chong-Jen Yu, Sang-We Kim, et al.
Medicine|June 4, 2016
Risk of Tuberculosis Among Patients on Dialysis: The Predictive Value of Serial Interferon-Gamma Release AssayChin-Chung Shu, Chia-Lin Hsu, Yu-Feng Wei, et al.
BMJ Open Respiratory Research|August 2, 2023
Deep learning with test-time augmentation for radial endobronchial ultrasound image differentiation: a multicentre verification studyKai-Lun Yu, Yi-Shiuan Tseng, Han-Ching Yang, et al.
Pageof 48